HIV-1 Gag p24 conserved elements and Interleukin-12 receptor pathway (p24CE/IL-12R)

The HIV-1 Gag p24 conserved elements and Interleukin-12 (IL-12) receptor pathway represent a dual-component immunotherapeutic strategy designed to elicit broad and potent cellular immune responses against HIV-1. The p24 conserved elements (p24CE) are highly invariant regions of the viral capsid protein that are critical for viral structure and replication; targeting these regions prevents the virus from escaping immune pressure through simple mutations [1]. The IL-12 receptor pathway serves as a critical co-stimulatory component, where the cytokine IL-12 acts as a molecular adjuvant to drive the differentiation of T cells into a Th1 phenotype, characterized by high production of interferon-gamma (IFN-gamma) and enhanced cytotoxic T-lymphocyte (CTL) activity [2][3]. This combination is typically delivered via DNA vaccine platforms, where plasmids encoding the p24CE antigens and IL-12 are co-administered to focus the immune response on vulnerable viral epitopes while providing the necessary inflammatory signals for robust activation [1][2]. Clinical and preclinical evaluations have shown that this approach can significantly increase the breadth and magnitude of T-cell responses compared to traditional vaccines using full-length Gag proteins [2]. Consequently, this target pathway is a focal point for developing next-generation therapeutic vaccines intended to control viral load in HIV-infected individuals [1]. Sources: [1] Kulkarni, V., et al. (2013). HIV-1 p24 conserved elements DNA vaccine elicits strong immune responses. PLoS ONE. [2] Felber, B. K., et al. (2014). Co-immunization with DNA vaccines expressing HIV-1 envelope and Gag conserved elements. Vaccine. [3] Trinchieri, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology.

Other names

p24CEHIV-1 p24 conserved elementsIL-12 adjuvant pathwayp24CE+IL-12 DNA vaccineConserved elements of HIV-1 Gag

Induction of T-cell mediated immunity against conserved viral epitopes enhanced by IL-12-mediated Th1 polarization.